Fund manager with 20% gain this year sees good times ahead as FDA becomes ‘more accommodating’

Ziad Bakri, manager of the T. Rowe Price Health Sciences Fund, looks for three main themes in his stock picks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.